Treatment of acute kidney injury with continuous renal replacement therapy and cytokine adsorber (CytoSorb®) in critically ill patients with COVID-19.

Eva Jakopin Masa KnehtlNina Vodošek HojsSebastjan Bevc Nejc PikoRadovan HojsRobert Ekart

Published in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2024)

Treatment with CRRT and cytokine adsorber may have positively influenced 60-day survival in our COVID-19 ICU patients with AKI.

Keyphrases

acute kidney injury
cardiac surgery
coronavirus disease
sars cov
intensive care unit
combination therapy
respiratory syndrome coronavirus